tech&fest

EPYNEXT THERAPEUTICS

Leveraging AI capabilities, Epynext Therapeutics develop a new generation of monoclonal antibodies targeting mutli-resistant bacteria

Univers

Grenoble Alpes Métropole

Exposants liés